Showing results (81-90 of 293) with videos related to
Sort By:
Pageof 30
Alzheimer Disease and Associated Disorders|July 14, 2004
A multinational review of recent trends and reports in dementia caregiver burdenFrank M Torti, Lisa P Gwyther, Shelby D Reed, et al.Cancer|October 20, 2004
Cost-effectiveness of imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemiaShelby D Reed, Kevin J Anstrom, Jennifer A Ludmer, et al.American Heart Journal|May 17, 2011
Do heart failure disease management programs make financial sense under a bundled payment system?Zubin J Eapen, Shelby D Reed, Lesley H Curtis, et al.Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 18, 2003
A Bayesian approach to aid in formulary decision making: incorporating institution-specific cost-effectiveness data with clinical trial resultsShelby D Reed, Peter W Dillingham, Andrew H Briggs, et al.Health Affairs (Project Hope)|August 7, 2008
Use of larger versus smaller drug-safety databases before regulatory approval: the trade-offsShelby D Reed, Kevin J Anstrom, Damon M Seils, et al.Cancer|October 20, 2004
Long-term survival estimates for imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemiaKevin J Anstrom, Shelby D Reed, Andrew S Allen, et al.Journal of Clinical Epidemiology|March 19, 2020
Reporting guidelines of health research studies are frequently used inappropriatelyLisa Caulley, Ferrán Catalá-López, Jonathan Whelan, et al.Pharmacoeconomics - Open|December 17, 2024
Incorporating Resource Constraints in Health Economic Evaluations: Overview and Methodological ConsiderationsPraveen Thokala, Henrique Duarte, Stuart Wright, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 12, 2025
Unlocking Patient Preferences: The Potential of Stated-Preference Methods in Clinical Decision MakingSemra Ozdemir, Jorien Veldwijk, Janine van Til, et al.JID Innovations : Skin Science From Molecules to Population Health|July 13, 2026
Economic evaluation of added neoadjuvant cemiplimab to upfront wide local excision for advanced cutaneous squamous cell carcinoma of the head and neckChristian L Bailey-Burke, David M Brizel, Peter A Ubel, et al.Pageof 30